Moreover, a study of EC patients who received neoadjuvant chemotherapy (NAC) followed by surgery demonstrated that high tumor CD163+ M2 macrophage infiltration is an independent predictor of response to NAC, and associated with poor prognosis and OS (43). This evidence concerns the gene CD163 and neoplasm.